| Genomic hallmarks and structural variation in metastatic prostate cancer DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ... Cell 174 (3), 758-769. e9, 2018 | 657 | 2018 |
| The DNA methylation landscape of advanced prostate cancer SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ... Nature genetics 52 (8), 778-789, 2020 | 245 | 2020 |
| Human SUMO fusion systems enhance protein expression and solubility Z Wang, H Li, W Guan, H Ling, Z Wang, T Mu, FD Shuler, X Fang Protein expression and purification 73 (2), 203-208, 2010 | 49 | 2010 |
| UGT2B17 expedites progression of castration-resistant prostate cancers by promoting ligand-independent AR signaling H Li, N Xie, R Chen, M Verreault, L Fazli, ME Gleave, O Barbier, X Dong Cancer research 76 (22), 6701-6711, 2016 | 48 | 2016 |
| The 5-hydroxymethylcytosine landscape of prostate cancer M Sjöström, SG Zhao, S Levy, M Zhang, Y Ning, R Shrestha, A Lundberg, ... Cancer research 82 (21), 3888-3902, 2022 | 29 | 2022 |
| Blue fluorescent protein analogs as chemosensors for Zn2+ X Fang, H Li, G Zhao, X Fang, J Xu, W Yang Biosensors and Bioelectronics 42, 308-313, 2013 | 29 | 2013 |
| Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression H Li, N Xie, ME Gleave, X Dong Oncotarget 6 (24), 20474, 2015 | 28 | 2015 |
| HoxA13 regulates phenotype regionalization of human pregnant myometrium LL Liu, H Li, D Dargahi, O Shynlova, D Slater, SJM Jones, SJ Lye, X Dong The Journal of Clinical Endocrinology & Metabolism 100 (12), E1512-E1522, 2015 | 19 | 2015 |
| HoxA13 stimulates myometrial cells to secrete IL-1β and enhance the expression of contraction-associated proteins H Li, Y Yu, Y Shi, L Fazli, D Slater, S Lye, X Dong Endocrinology 157 (5), 2129-2139, 2016 | 17 | 2016 |
| The androgen receptor mediates antiapoptotic function in myometrial cells H Li, Y Li, D Morin, S Plymate, S Lye, X Dong Cell Death & Disease 5 (7), e1338-e1338, 2014 | 16 | 2014 |
| Loss of nuclear functions of HOXA10 is associated with testicular cancer proliferation R Chen, H Li, Y Li, L Fazli, M Gleave, L Nappi, X Dong Frontiers in Oncology 8, 594, 2018 | 14 | 2018 |
| In vivo evidence of the androgen receptor in association with myometrial cell proliferation and apoptosis M Lan, H Li, L Bao, M Li, S Lye, X Dong Reproductive Sciences 23 (2), 264-271, 2016 | 14 | 2016 |
| The genomic and epigenomic landscape of double-negative metastatic prostate cancer A Lundberg, M Zhang, R Aggarwal, H Li, L Zhang, A Foye, M Sjöström, ... Cancer Research 83 (16), 2763-2774, 2023 | 12 | 2023 |
| Di-nuclear nonionic magnetic resonance contrast agents using pyrazinyl linking centers H Li, C Lu, Y Xiao, X Fang, P Wang, X Fang, K Zhao, X Li, S Yin, J Xu, ... RSC advances 2 (16), 6404-6407, 2012 | 10 | 2012 |
| Optimization of a MT1-MMP-targeting peptide and its application in near-infrared fluorescence tumor imaging L Ren, Y Wang, L Zhu, L Shen, J Zhang, J Wang, H Li, Q Zheng, D Yu, ... Scientific Reports 8 (1), 10334, 2018 | 8 | 2018 |
| HoxA10 and HoxA11 regulate the expression of contraction-associated proteins and contribute to regionalized myometrium phenotypes in women Y Li, H Li, N Xie, R Chen, AR Lee, D Slater, S Lye, X Dong Reproductive Sciences 25 (1), 44-50, 2018 | 7 | 2018 |
| 5-hydroxymethylcytosine as a liquid biopsy biomarker in mCRPC. M Sjöström, S Zhao, EJ Small, Y Ning, C Maurice-Dror, A Foye, JJT Hua, ... Journal of Clinical Oncology 39 (6_suppl), 148-148, 2021 | 4 | 2021 |
| Catalytic topoisomerase II inhibitors suppress the androgen receptor signaling and prostate cancer progression H Li, N Xie, M Gleave, X Dong Cancer Research 75 (15_Supplement), 1846-1846, 2015 | 3 | 2015 |
| Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression M Zhang, M Sjöström, X Cui, A Foye, K Farh, R Shrestha, A Lundberg, ... Nature Cell Biology, 1-11, 2024 | 2 | 2024 |
| AR inhibition increases MHC class I expression and improves immune response in prostate cancer LN Chesner, JN Graff, F Polesso, A Smith, A Lundberg, R Das, T Shenoy, ... | 2 | 2023 |
